Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?

Assessing progression of disease or response to treatment remains a major challenge in the clinical management of nontuberculous mycobacterial (NTM) infections of the lungs. Serial assessments of validated measures of treatment response address whether the current therapeutic approach is on track to...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinnard, Christopher, Mezochow, Alyssa, Oakland, Hannah, Klingsberg, Ross, Hansen-Flaschen, John, Hamilton, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256187/
https://www.ncbi.nlm.nih.gov/pubmed/30524407
http://dx.doi.org/10.3389/fmicb.2018.02813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256187/
https://www.ncbi.nlm.nih.gov/pubmed/30524407
http://dx.doi.org/10.3389/fmicb.2018.02813

Ejemplares similares